Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vistin Pharma ASALTS:0RAM 76 3-Year Dividend Growth Rate is 0.00% as of Mar. 2026. GuruFocus rates LTS:0RAM with a GF Score™ of 76/100 and a GF Value™ of kr25.83 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 352 Drug Manufacturers companies, Vistin Pharma ASA ranks worse than 284090.63% on this metric.
The historical rank and industry rank for Vistin Pharma ASA's 3-Year Dividend Growth Rate or its related term are showing as below:
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Vistin Pharma ASA was 51.80% per year. The lowest was 0.70% per year. And the median was 26.25% per year.
LTS:0RAM's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.7 * Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
During the past 12 months, Vistin Pharma ASA's average Dividends Per Share Growth Rate was 25.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Vistin Pharma ASA is 0.73, which seems too high.
Warning Sign:
Vistin Pharma ASA stock Dividend Yield % is close to 1-year low.
For more information regarding to dividend, please check our Dividend Page.
During the past 13 years, the highest Dividend Payout Ratio of Vistin Pharma ASA was 3.06. The lowest was 0.65. And the median was 1.06.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Vistin Pharma ASA is 0.73, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Vistin Pharma ASA Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
NOK 1.000000
2026-05-22
2026-05-26
2026-05-29
Cash Dividend
semi-annually
NOK:NOK 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Vistin Pharma ASA's Dividend Yield (%) for Today is calculated as
Current Share Price is kr20.10.
Vistin Pharma ASA's Dividends per Share for the trailing twelve months (TTM) ended in Today is kr1.
During the past 13 years, the highest Dividend Yield of Vistin Pharma ASA was 9.22%. The lowest was 2.08%. And the median was 4.58%.
Warning Sign:
Vistin Pharma ASA stock Dividend Yield % is close to 1-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vistin Pharma ASA 3-Year Dividend Growth Rate Related Terms>
LTS:0RAM vs ZTS, UTHR, VTRS: 3-Year Dividend Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vistin Pharma ASA 3-Year Dividend Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Vistin Pharma ASA's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 0.00% mean?
Vistin Pharma ASA (LTS:0RAM) has a 3-Year Dividend Growth Rate of 0.00% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Vistin Pharma ASA and its competitors. Over the past decade, Vistin Pharma ASA's 3-Year Dividend Growth Rate has ranged from 0.70 to 51.80. According to the industry distribution chart, Vistin Pharma ASA ranks #999999 out of 352 companies in the Drug Manufacturers industry.
Is Vistin Pharma ASA's 3-Year Dividend Growth Rate too high?
Vistin Pharma ASA's current 3-Year Dividend Growth Rate is 0.00%. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 51.80. Based on the distribution chart, Vistin Pharma ASA ranks #999999 out of 352 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Vistin Pharma ASA has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vistin Pharma ASA's 3-Year Dividend Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vistin Pharma ASA ranks #999999 out of 352 companies for 3-Year Dividend Growth Rate. This places Vistin Pharma ASA in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 7.70. Historically, Vistin Pharma ASA's own 3-Year Dividend Growth Rate has ranged from 0.70 to 51.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 3-Year Dividend Growth Rate among Drug Manufacturers companies is 7.70, based on 352 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Vistin Pharma ASA and its competitors. For the Drug Manufacturers industry, the median 3-Year Dividend Growth Rate is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vistin Pharma ASA's current 3-Year Dividend Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vistin Pharma ASA stock overvalued right now?
Based on GuruFocus' analysis, Vistin Pharma ASA (LTS:0RAM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr25.83, compared to a current price of kr20.10 — trading 22.2% below its estimated fair value. The current 3-Year Dividend Growth Rate is 0.00%. Vistin Pharma ASA's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Vistin Pharma ASA (LTS:0RAM), the current 3-Year Dividend Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vistin Pharma ASA (LTS:0RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued.
The current stock price of kr20.10 is trading 22.2% below its estimated GF Value™ of kr25.83.
GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.
Key valuation signals for LTS:0RAM:
3-Year Dividend Growth Rate: 0.00%
GF Value™: kr25.83 vs. price of kr20.10 (22.2% below fair value)
No single metric tells the full story. See the LTS:0RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
76GF Score
Get the complete analysis for LTS:0RAM
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RAM has been successfully added to your 
